Glaxo Loses Paxil Suit At Federal Circuit
In a blow to U.K. drug maker GlaxoSmithKline, the U.S. Court of Appeals for the Federal Circuit has ruled in favor of Canadian generics maker Apotex in a patent infringement lawsuit...To view the full article, register now.
Already a subscriber? Click here to view full article